JPMA Official Praises Sakigake System as “Ground-Breaking,” Expresses Concern Over Impact of Compassionate Use System

May 12, 2015
Masaaki Kuwahara, chairman of the Japan Pharmaceutical Manufacturers Association’s (JPMA) Regulatory Affairs Committee, praised what is called the “ sakigake ” designation system as “ground-breaking” at a symposium held by the Society for Regulatory Science of Medical Products on May...read more